Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$195.11 USD
+1.24 (0.64%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $195.15 +0.04 (0.02%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth C Momentum C VGM
Price, Consensus and EPS Surprise
CRL 195.11 +1.24(0.64%)
Will CRL be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CRL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CRL
CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica
CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services
CRL Stock May Benefit From New Neuroscience Research Collaboration
Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report?
Why Charles River (CRL) International Revenue Trends Deserve Your Attention
Other News for CRL
Charles River Laboratories International Moves Up In Market Cap Rank, Passing Hasbro
Analysts Conflicted on These Healthcare Names: Penumbra (PEN), Nurix Therapeutics (NRIX) and Charles River Labs (CRL)
Charles River price target lowered by $5 at Barclays, here's why
Charles River initiated with bearish view at Redburn Atlantic, here's why
Charles River Laboratories International Inc (CRL) Stock Price Up 3.22% on Oct 10